Bone Biologics (BBLG) EBIT Margin (2023 - 2024)
Bone Biologics' EBIT Margin came in at -1.91% for FY2016.
Powered by 
Analysis
Bone Biologics (BBLG) EBIT Margin (2023 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.71 Bn | 229.74 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 178.38 Bn | 148.81 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 154.15 Bn | 134.44 Bn | 2.08 Bn | 19.44% |
| 5 | Medtronic | 123.21 Bn | 88.46 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 117.50 Bn | 103.61 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 67.50 Bn | 62.26 Bn | 3.85 Bn | 21.65% |
| 8 | Becton Dickinson | 54.80 Bn | 51.95 Bn | 2.32 Bn | 13.31% |
| 9 | Edwards Lifesciences | 51.78 Bn | 35.79 Bn | 1.35 Bn | 29.48% |
| 10 | Bone Biologics | 705,226.36 | -21.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -354,327.84% |
| Dec 31, 2023 | -332,380.52% |
| Sep 30, 2023 | -388,225.75% |
| Jun 30, 2023 | -710,249.53% |
| Mar 31, 2023 | -566,103.78% |
API Access
Bone Biologics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BBLG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();